Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · National Healthcare (NHC)

National HealthCare adds director Lisa Piercey; CEO Flatt to also serve as president

Neutral Impact 3 of 5 leadership Written later

National HealthCare appointed Dr. Lisa Piercey to its board effective November 6, 2025, and named her to the Audit Committee. The company also said President and COO R. Michael Ussery will retire December 31, 2025, after which CEO Stephen F. Flatt will also serve as president and Timothy J. Shelly will become principal operating officer.

Key points

  • Dr. Lisa Piercey appointed director effective November 6, 2025; independent director and Audit Committee member
  • Piercey is intended as a nominee for a three-year term at the 2026 Annual Meeting of Shareholders
  • R. Michael Ussery retires as President and COO effective December 31, 2025
  • Stephen F. Flatt, CEO since January 1, 2017, will also serve as president; Timothy J. Shelly becomes principal operating officer

The filing

CompanyNational Healthcare (NHC)
Form8-K, current report
Filed with the SECNov 12, 2025, 4:17 PM ET
Accession number0001437749-25-034451

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 12, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.